Form Type: 4

SEC EDGAR Link
Accession Number:0001179110-20-007793
Date:2020-06-24
Issuer: BLUEPRINT MEDICINES CORP (BPMC)
Original Submission Date:

Reporting Person:

ROWLAND CHARLES A JR
C/O BLUEPRINT MEDICINES CORPORATION
45 SIDNEY STREET CAMBRIDGE, MA 02139

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2020-06-24 A 2,250 a $0.00 3,562 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 76.24 2020-06-24 deemed execution date A 4,500 (a) 2030-06-24 common stock 4,500 $76.24 4,500 direct
Footnotes
IDfootnote
f1 the reported transaction involved the reporting person's receipt of a grant of restricted stock units. the restricted stock units vest with respect to 100% of the shares underlying the restricted stock units on the earlier of (i) the next annual meeting of the issuer's stockholders and (ii) june 24, 2021. each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
f2 this option vests with respect to 100% of the shares underlying the option on the earlier of (i) the next annual meeting of the issuer's stockholders and (ii) june 24, 2021.
WhaleWisdom Logo

Elevate your investments